Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 525

The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Open access
Zappasodi, Roberta, Merghoub, Taha, Wolchok, Jedd D.·2018·Cancer Cell

Abstract

Checkpoint blockade has formally demonstrated that reactivating anti-tumor immune responses can regress tumors. However, this only occurs in a fraction of patients. Incorporating these therapies in more powerful combinations is thus a logical next step. Here, we review functional roles of immune checkpoints and molecular determinants of checkpoint-blockade clinical activity. Limited-size T-cell-infiltrated tumors, differing substantially from “self”, generally respond to checkpoint blockade. Therefore, we propose that reducing tumor burden and increasing tumor immunogenicity are key factors to improve immunotherapy. Lastly, we outline criteria to select proper immunotherapy combination partners and highlight the importance of activity biomarkers for timely treatment optimization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2018.03.005

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Zappasodi, 2016, Abstract PR06: overcoming intratumor T-cell exclusion by modulation of lactate metabolism to improve immune checkpoint therapies in aggressive breast cancer, Cancer Immunol. Res., 4, PR06, 10.1158/2326-6066.IMM2016-PR06 · doi:10.1158/2326-6066.imm2016-pr06
  2. Zappasodi, 2017, Abstract CT018: intratumor and peripheral Treg modulation as a pharmacodynamic biomarker of the GITR agonist antibody TRX-518 in the first in-human trial, Cancer Res., 77, CT018, 10.1158/1538-7445.AM2017-CT018 · doi:10.1158/1538-7445.am2017-ct018

Cited by

See all 525

Metadata

Authors
Zappasodi, R., Merghoub, T., & Wolchok, J. D.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2018-04
Volume
33
Issue
4
Pages
581-598
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2796643083
Cited by
525
References
198
FWCI
24.10
Type
journal article
Language
en
Update notices
erratum (2018-10-08)
Open access
bronze
Licence
Funders
  • Ludwig Institute for Cancer Research
  • National Institutes of Health
  • National Cancer Institute (P30 CA008748)
  • Parker Institute for Cancer Immunotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.